scispace - formally typeset
S

Sui-Yuan Chang

Researcher at National Taiwan University

Publications -  212
Citations -  4583

Sui-Yuan Chang is an academic researcher from National Taiwan University. The author has contributed to research in topics: Medicine & Men who have sex with men. The author has an hindex of 32, co-authored 169 publications receiving 3551 citations. Previous affiliations of Sui-Yuan Chang include Academia Sinica & Harvard University.

Papers
More filters
Journal ArticleDOI

Hepatitis E Virus Infections Among Human Immunodeficiency Virus-Positive Individuals During an Outbreak of Acute Hepatitis A in Taiwan.

TL;DR: HEV endemicity remained low among HIV‐positive patients in Taiwan during the outbreak of acute hepatitis A, and the data suggest that sexual transmission of HEV with significant morbidity ofHEV infection, if any, is rare in this population.
Journal Article

Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.

TL;DR: Bacteremia, infective endocarditis and tuberculosis were the three most common patterns of infection among HIV-infected IDUs who sought medical care at a referral hospital; and methicillin-sensitive S. aureus was the most common etiology of bacterenmia.
Journal ArticleDOI

Incidence of acute pancreatitis in human immunodeficiency virus-positive patients with hypertriglyceridemia: is it really high?

TL;DR: The risk of acute pancreatitis was low among human immunodeficiency virus–positive patients who developed hypertriglyceridemia after receiving highly active antiretroviral therapy.
Posted ContentDOI

Distinct Inductions of and Responses to Type I and Type III Interferons PromoteInfections in Two SARS-CoV-2 Isolates

TL;DR: It is found that the patient serum could not efficiently neutralize SARS-CoV-2 virions, and poor induction and response to innate immunity may contribute to destitute neutralization index of the antibody produced, and indeed this report may provide new insights for the regimen of therapies for Sars-Cov-2 infected patients.
Journal ArticleDOI

Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2.

TL;DR: In this paper, Remdesivir and cyclosporine, a prodrug targeting RNA-dependent-RNA-polymerase, and calcineurin inhibitor, individually exerted inhibitory activity against human coronavirus OC43 (HCoV-OC43) in HCT-8 and MRC-5 cells at EC50 values of 96 ± 34 and 85 ± 23 nM, respectively.